Class information for:
Level 1: CYCLOOXYGENASE 2//COX 2//CELECOXIB

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
203 3878 44.9 89%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
670 12541 CYCLOOXYGENASE 2//COX 2//CYCLOOXYGENASE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CYCLOOXYGENASE 2 Author keyword 97 17% 14% 529
2 COX 2 Author keyword 84 16% 12% 481
3 CELECOXIB Author keyword 75 22% 8% 298
4 SULINDAC Author keyword 37 37% 2% 81
5 COX 2 INHIBITOR Author keyword 14 22% 1% 55
6 NS 398 Author keyword 9 25% 1% 32
7 CYCLOOXYGENASE 2 COX 2 Author keyword 8 17% 1% 40
8 COX 2 EXPRESSION Author keyword 6 38% 0% 13
9 SC 560 Author keyword 5 35% 0% 11
10 GASTROINTESTINAL OTHER CANC GRP Address 5 41% 0% 9

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 CYCLOOXYGENASE 2 97 17% 14% 529 Search CYCLOOXYGENASE+2 Search CYCLOOXYGENASE+2
2 COX 2 84 16% 12% 481 Search COX+2 Search COX+2
3 CELECOXIB 75 22% 8% 298 Search CELECOXIB Search CELECOXIB
4 SULINDAC 37 37% 2% 81 Search SULINDAC Search SULINDAC
5 COX 2 INHIBITOR 14 22% 1% 55 Search COX+2+INHIBITOR Search COX+2+INHIBITOR
6 NS 398 9 25% 1% 32 Search NS+398 Search NS+398
7 CYCLOOXYGENASE 2 COX 2 8 17% 1% 40 Search CYCLOOXYGENASE+2+COX+2 Search CYCLOOXYGENASE+2+COX+2
8 COX 2 EXPRESSION 6 38% 0% 13 Search COX+2+EXPRESSION Search COX+2+EXPRESSION
9 SC 560 5 35% 0% 11 Search SC+560 Search SC+560
10 SELECTIVE COX 2 INHIBITOR 4 31% 0% 12 Search SELECTIVE+COX+2+INHIBITOR Search SELECTIVE+COX+2+INHIBITOR

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ASPIRIN USE 267 52% 9% 362
2 AUTOCHTHONOUS INTESTINAL TUMORS 99 97% 1% 29
3 FAMILIAL ADENOMATOUS POLYPOSIS 91 16% 14% 537
4 SULINDAC 84 35% 5% 192
5 SULINDAC SULFIDE 83 61% 2% 89
6 CYCLOOXYGENASE 2 INHIBITOR 78 26% 7% 259
7 CYCLOOXYGENASE 2 EXPRESSION 73 18% 10% 378
8 SELECTIVE CYCLOOXYGENASE 2 INHIBITOR 71 40% 4% 138
9 COX 2 64 18% 8% 314
10 CELECOXIB 59 17% 8% 311

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Estimates of benefits and harms of prophylactic use of aspirin in the general population 2015 16 45 49%
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement 2009 242 56 71%
The COX-2/PGE(2) pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment 2009 377 157 41%
Eicosanoids and cancer 2010 397 148 30%
Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues 2002 790 185 72%
Aspirin and cancer risk: a quantitative review to 2011 2012 80 104 79%
Prostaglandins and cancer 2006 399 111 46%
COX-2 as a target for cancer chemotherapy 2010 110 65 74%
Cyclooxygenase 2: a molecular target for cancer prevention and treatment 2003 391 60 73%
The role of aspirin in cancer prevention 2012 93 59 56%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 GASTROINTESTINAL OTHER CANC GRP 5 41% 0.2% 9
2 HANGZHOU HOSP 3 26% 0.3% 11
3 ADV MICROSCOP DIS 3 100% 0.1% 3
4 GASTROINTESTINAL HEPATOBILIARY PANCREAT CANC 2 67% 0.1% 2
5 JAMES H QUILLEN VET ADM MED 2 67% 0.1% 2
6 LUNG CANC PROGRAM 2 11% 0.5% 18
7 INTEGRATED CANC PREVENT 2 17% 0.3% 10
8 GENE THER Y CELLULAR ENGN 2 43% 0.1% 3
9 MOL GENET BIOFUNCT 2 19% 0.2% 7
10 STRANG CANC 1 12% 0.3% 11

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000236156 CYCLOOXYGENASE 2 GENE//PTGS2//COX 2 GENE
2 0.0000207945 CALPAIN 9//CT26 COLORECTAL ADENOCARCINOMA//DELTA PSIM
3 0.0000127345 SALICYLIDENEAMINO 2 THIOPHENOL//GAMABUFOTALIN//INFLAMMATION CONTROL
4 0.0000108386 MPGES 1//PROSTAGLANDIN E SYNTHASE//MPGES 2
5 0.0000105699 15 HYDROXYPROSTAGLANDIN DEHYDROGENASE//PROSTAGLANDIN TRANSPORTER//15 PGDH
6 0.0000093116 PROSTAGLANDIN H SYNTHASE//IMRECOXIB//AB HANCOCK JR MEM CANC
7 0.0000078370 CASPASE 14//SUNBURN CELL//DEATH RECEPTOR ACTIVATION
8 0.0000068089 NO ASPIRIN//NITROASPIRIN//NCX 4016
9 0.0000059126 MIN MOUSE//MIN MICE//FAP MODEL
10 0.0000045947 ABERRANT CRYPT FOCI//BETA CATENIN ACCUMULATED CRYPTS//COLON CARCINOGENESIS